Buscar resultados de ensayos clínicos
Choroidal Neovascularization - 25 Studies Found
Estado | Estudiar |
Withdrawn |
Nombre del estudio: Phase II Study Evaluating the Efficacy of Aflibercept for the Treatment of Choroidal Neovascularization in Angioid Streaks in Young Patients (ASTRID). Condición: Choroidal Neovascularization in Angioid Streaks Fecha: 2015-10-07 Intervenciones: Drug: Aflibercept The patients are followed on a monthly basis until 52 weeks. Intravitreal injections o |
Completed |
Nombre del estudio: Assess the Efficacy/Safety of Intravitreal Ranibizumab in Patients With Vision Loss Due to Choroidal Neovascularization. Condición: Choroidal Neovascularization (CNV) Fecha: 2013-04-23 Intervenciones:
|
Completed |
Nombre del estudio: Comparative Study With Photodynamic Therapy And Triamcinolone Versus Photodynamic Therapy, Triamcinolone And Ranibizumab In Patients With Subfoveal Choroidal Neovascularization Condición: Subfoveal Choroidal Neovascularization Fecha: 2006-12-01 Intervenciones:
|
Completed |
Nombre del estudio: Efficacy and Safety of Ranibizumab 0.5 vs Veteporfin PDT in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia Condición: Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia Fecha: 2013-08-12 Intervenciones:
|
Completed |
Nombre del estudio: Safety Study of Ranibizumab Eye Injections to Treat Choroidal Neovascularization That Was Caused Other Than by Age-Related Macular Degeneration. Condición: Choroidal Neovascularization Fecha: 2006-11-01 Intervenciones: Drug: ranibizumab 0.5mg intravitreal injection |
Completed |
Nombre del estudio: Use of Intravitreal Bevacizumab in Eyes With Choroidal Neovascularization Secondary to Angioid Streaks Condición:
Fecha: 2006-06-30 Intervenciones: Drug: Intravitreal Bevacizumab |
Completed |
Nombre del estudio: Safety and Efficacy Study of Combretastatin A4 Phosphate to Treat Patients With Choroidal Neovascularization Secondary to Pathologic Myopia Condición:
Fecha: 2011-08-22 Intervenciones: Drug: Combretastatin A-4 Phosphate Combretastatin A-4 Phosphate is administered on Day 0 and Day 7 (+/- |
Recruiting |
Nombre del estudio: AVENUE: A Proof-of-Concept Study of RG7716 in Participants With Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD) Condición: Macular Degeneration, Choroidal Neovascularization Fecha: 2015-06-12 Intervenciones:
|
Completed |
Nombre del estudio: Efficacy/Safety of Verteporfin Photodynamic Therapy and Ranibizumab Compared With Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Condición:
Fecha: 2007-02-16 Intervenciones:
|
Completed |
Nombre del estudio: A Study of the Criteria Establishing the Need for Re-treatment With Ranibizumab Upon Relapse in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia. Condición: Choroidal Neovascularization Secondary to Pathologic Myopia Fecha: 2014-01-09 Intervenciones: Drug: Ranibizumab All patients will receive a single initial intravitreal injection of ranibizumab 0.5 m |